-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Cyclacel Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Cyclacel Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$2.18M, a 68.2% increase year-over-year.
- Cyclacel Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$15.5M, a 46.3% increase year-over-year.
- Cyclacel Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$25.5M, a 7.97% increase from 2022.
- Cyclacel Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$27.7M, a 23.5% decline from 2021.
- Cyclacel Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$22.4M, a 111% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)